Pharmaceutical composition comprising meta arsenite and method of manufacture
US12257347B2 · kind B2 · utility
0Cited by
7References
27Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Mar 21, 2019 |
| Grant date | Mar 25, 2025 |
| Priority date | — |
| Expiry date | May 22, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2866
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to pharmaceutical compositions comprising a salt of arsenous acid, such as sodium meta arsenite or potassium meta arsenite, and methods of manufacturing the pharmaceutical compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.